MedPath

好医生药业集团有限公司

Ownership
-
Established
1998-12-18
Employees
-
Market Cap
-
Website
https://www.hys.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

98

NMPA:98

Drug Approvals

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20243756
Approval Date
May 21, 2024
NMPA

心脑欣片

Approval Number
国药准字Z20090342
Approval Date
Aug 23, 2023
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H20064872
Approval Date
May 30, 2023
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H20064873
Approval Date
May 30, 2023
NMPA

Ampicillin for Suspension

Product Name
氨苄西林干混悬剂
Approval Number
国药准字H21023783
Approval Date
May 30, 2023
NMPA

穿黄清热胶囊

Approval Number
国药准字Z20080341
Approval Date
Mar 9, 2023
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H21023528
Approval Date
Mar 9, 2023
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H21023907
Approval Date
Mar 2, 2023
NMPA

Amoxicillin Tablets

Product Name
阿莫西林片
Approval Number
国药准字H21024367
Approval Date
Mar 1, 2023
NMPA

Amoxicillin Tablets

Product Name
阿莫西林片
Approval Number
国药准字H21023908
Approval Date
Mar 1, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.